BBC icon

Virtus LifeSci Biotech Clinical Trials ETF

18 hedge funds and large institutions have $16.2M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

less funds holding

Funds holding:

less capital invested

Capital invested by funds: $ → $

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
18
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$3.9M
2
$3.58M
3
$2.61M
4
$1.9M
5
$1.41M
6
$580K
7
$577K
8
$556K
9
$487K
10
$418K
11
$42K
12
$39K
13
$27K
14
$26K
15
$21K
16
$16K
17
$10K
18
$5.18K
19
20
21
22